Comprehensive analysis of the factors contributing to the stability and solubility of autonomous human VH domains

被引:142
作者
Barthelemy, Pierre A. [1 ]
Raab, Helga [2 ]
Appleton, Brent A. [1 ]
Bond, Christopher J. [1 ]
Wu, Ping [1 ]
Wiesmann, Christian [1 ]
Sidhu, Sachdev S. [1 ]
机构
[1] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA
关键词
D O I
10.1074/jbc.M708536200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report a comprehensive analysis of sequence features that allow for the production of autonomous human heavy chain variable (V-H) domains that are stable and soluble in the absence of a light chain partner. Using combinatorial phage- displayed libraries and conventional biophysical methods, we analyzed the entire former light chain interface and the third complementarity determining region (CDR3). Unlike the monomeric variable domains of camelid heavy chain antibodies (VHH domains), in which autonomous behavior depends on interactions between the hydrophobic former light chain interface and CDR3, we find that the stability of many in vitro evolved V-H domains is essentially independent of the CDR3 sequence and instead derives from mutations that increase the hydrophilicity of the former light chain interface by replacing exposed hydrophobic residues with structurally compatible hydrophilic substitutions. The engineered domains can be expressed recombinantly at high yield, are predominantly monomeric at high concentrations, unfold reversibly, and are even more thermostable than typical camelid VHH domains. Many of the stabilizing mutations are rare in natural V-H and VHH domains and thus could not be predicted by studying natural sequences and structures. The results demonstrate that autonomous V-H domains with structural properties beyond the scope of natural frameworks can be derived by using non- natural mutations, which differ from those found in camelid VHH domains. These findings should enable the development of libraries of synthetic V-H domains with CDR3 diversities unconstrained by structural demands.
引用
收藏
页码:3639 / 3654
页数:16
相关论文
共 74 条
  • [1] SELECTION OF HUMAN ANTIHAPTEN ANTIBODIES FROM SEMISYNTHETIC LIBRARIES
    BARBAS, CF
    AMBERG, W
    SIMONCSITS, A
    JONES, TM
    LERNER, RA
    [J]. GENE, 1993, 137 (01) : 57 - 62
  • [2] A structure-based database of antibody variable domain diversity
    Bond, CJ
    Wiesmann, C
    Marsters, JC
    Sidhu, SS
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2005, 348 (03) : 699 - 709
  • [3] Contributions of CDR3 to VHH domain stability and the design of monobody scaffolds for naive antibody libraries
    Bond, CJ
    Marsters, JC
    Sidhu, SS
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2003, 332 (03) : 643 - 655
  • [4] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [5] HUMANIZATION OF AN ANTI-P185HER2 ANTIBODY FOR HUMAN CANCER-THERAPY
    CARTER, P
    PRESTA, L
    GORMAN, CM
    RIDGWAY, JBB
    HENNER, D
    WONG, WLT
    ROWLAND, AM
    KOTTS, C
    CARVER, ME
    SHEPARD, HM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) : 4285 - 4289
  • [6] HIGH-LEVEL ESCHERICHIA-COLI EXPRESSION AND PRODUCTION OF A BIVALENT HUMANIZED ANTIBODY FRAGMENT
    CARTER, P
    KELLEY, RF
    RODRIGUES, ML
    SNEDECOR, B
    COVARRUBIAS, M
    VELLIGAN, MD
    WONG, WLT
    ROWLAND, AM
    KOTTS, CE
    CARVER, ME
    YANG, M
    BOURELL, JH
    SHEPARD, HM
    HENNER, D
    [J]. BIO-TECHNOLOGY, 1992, 10 (02): : 163 - 167
  • [7] Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
    Cho, HS
    Mason, K
    Ramyar, KX
    Stanley, AM
    Gabelli, SB
    Denney, DW
    Leahy, DJ
    [J]. NATURE, 2003, 421 (6924) : 756 - 760
  • [8] Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs
    Conrath, KE
    Lauwereys, M
    Wyns, L
    Muyldermans, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) : 7346 - 7350
  • [9] Efficient tumor targeting by single-domain antibody fragments of camels
    Cortez-Retamozo, V
    Lauwereys, M
    Gh, GH
    Gobert, M
    Conrath, K
    Muyldermans, S
    De Baetselier, P
    Revets, H
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (03) : 456 - 462
  • [10] CAMELISING HUMAN-ANTIBODY FRAGMENTS - NMR-STUDIES ON VH DOMAINS
    DAVIES, J
    RIECHMANN, L
    [J]. FEBS LETTERS, 1994, 339 (03) : 285 - 290